市場調查報告書
商品編碼
1534364
眼科器材市場:全球規模、佔有率、趨勢分析、機會、預測,2019-2030Ophthalmological Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Devices; By End User; By Region |
2030年全球眼科器材市場規模將成長至570億美元
由於眼科疾病盛行率不斷上升、人口迅速老化、眼睛健康意識不斷增強以及對微創手術的需求不斷成長,全球眼科器械市場正在蓬勃發展。
領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計,2023 年全球眼科器材市場規模將以金額為準412 億美元。 BlueWeave 預測,在 2024 年至 2030 年的預測期內,全球眼科器材市場規模將以 4.80% 的複合年成長率成長,並於 2030 年達到 570 億美元。技術進步、新興國家對設備的需求不斷增加以及人們對眼睛健康意識的提高是全球眼科設備市場的主要成長要素。新興國家可支配收入的增加和醫療基礎設施的改善為市場公司提供了成長機會。主要策略包括新產品發布、業務擴張、收購、合作夥伴關係和細胞療法。眼科手術(例如超音波和雷射輔助手術)的進步提高了治療效果和視力預防。
機會-更多採用創新技術
由於神經移植治療、生物工程角膜、人造角膜、視網膜移植、乾眼症檢測、人工水晶體、隱形眼鏡、雷射等方面的進步,全球眼科器械市場預計將成長。穿戴式 AR/VR 護目鏡、基於人工智慧的治療方法和生物感測器也有潛力增強眼科檢查和監測。因此,先進技術的快速採用可能會在未來幾年推動全球眼科器械市場的成長。
北美主導全球市場
按地區分類,北美在全球眼科器械市場中佔據主導地位。北美市場的主導地位主要是由先進的醫療基礎設施、眼科疾病的高盛行率、先進眼科技術的大量採用以及不斷上漲的醫療成本所推動的。大型市場參與者和完善的醫療保健系統的存在也是北美在全球市場中保持主導地位的因素。
地緣政治緊張局勢加劇對全球眼科器材市場的影響
地緣政治緊張局勢的加劇對全球眼科器械市場產生重大影響。貿易限制和關稅擾亂了供應鏈,增加了生產成本並延遲了重要零件的交付。製造商和醫療保健提供者在維持庫存和滿足需求方面面臨挑戰。此外,受影響地區的外匯波動和經濟不穩定可能導致眼科設備價格上漲,並降低患者的可及性。經濟不確定性可能會減少研發投資,進而可能減緩該領域的創新。此外,醫療保健預算可能會被重新調整以解決眼前的地緣政治危機,從而影響眼保健的資金。總的來說,這些因素可能是一個可變因素,阻礙全球眼科器械市場的成長。
競爭格局
全球眼科器械市場競爭激烈,眾多公司爭奪更大的市場佔有率。市場主要企業包括愛爾康公司、博士健康公司、卡爾蔡司醫療公司、EssilorLuxottica SA、HAAG-Streit Group、霍亞公司、強生公司、尼德克有限公司、拓普康公司、齊默眼科系統公司、 Volk Optical, Inc. 和徠卡顯微系統公司。這些公司正在採用各種策略來在全球眼科器械市場中定位自己,包括增加對研發活動的投資、併購、合資企業、聯盟、許可協議以及新產品和服務 它的發布,並進一步加強。
該報告的詳細分析提供了有關全球眼科器械市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場規模預測的因素。該報告致力於提供全球眼科器材市場的最新技術趨勢以及產業見解,以幫助決策者做出適當的策略決策。此外,我們也分析了市場的成長動力、挑戰和競爭力。
Global Ophthalmological Devices Market Size Expanding to Reach Value of USD 57 Billion by 2030
Global Ophthalmological Devices Market is flourishing due to the growing prevalence of eye diseases, the rapidly aging population, rising awareness about eye health, and an increasing demand for minimally invasive surgical procedures.
BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated Global Ophthalmological Devices Market size by value at USD 41.2 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Ophthalmological Devices Market size to expand at a CAGR of 4.80% reaching a value of USD 57 billion in 2030. Technological advancements, rising demand for the devices from emerging economies, and increasing awareness about eye health are major growth factors for Global Ophthalmological Devices Market. Rising disposable income and improved healthcare infrastructure in developing countries create growth opportunities for the market players. Key strategies include new product launches, expansion, acquisitions, partnerships, and cell-based treatments. Advancements in eye surgery, such as phacoemulsification and laser-assisted procedures, have improved treatment efficacy and vision prevention.
Opportunity - Growing adoption of innovative technologies
The Ophthalmological Devices Market across the globe is expected to grow due to advancements in nerve transplant treatments, bioengineered Corneas, artificial corneas, retinal implants, dry eye syndrome detection, intraocular lenses, contact lenses, and lasers. Wearable AR and VR goggles, AI-based therapies, and biosensors could also enhance eye tests and monitoring. Hence, rapid adoption of advanced technologies could boost the growth of Global Ophthalmological Devices Market in the coming years.
North America Region Dominates the Global Market
North America dominates Global Ophthalmological Devices Market by region. The market dominance of North America is primarly driven by advanced healthcare infrastructure, a high prevalence of eye disorders, significant adoption of advanced ophthalmological technologies, and increasing healthcare expenditure. The presence of major market players and a well-established healthcare system also contribute to North America's leadership position in the global market.
Impact of Escalating Geopolitical Tensions on Global Ophthalmological Devices Market
Escalating geopolitical tensions significantly impact Global Ophthalmological Devices Market. Trade restrictions and tariffs disrupt the supply chain, leading to increased production costs and delayed delivery of essential components. It creates challenges for manufacturers and healthcare providers in maintaining inventory and meeting demand. Additionally, fluctuating exchange rates and economic instability in affected regions can result in higher prices for ophthalmological devices, reducing accessibility for patients. Investment in research and development may decline due to economic uncertainties, stalling innovations in the field. Furthermore, healthcare budgets might be redirected to address immediate geopolitical crises, impacting funding for ophthalmological care. These factors collectively contribute to volatility and may hinder the growth of Global Ophthalmological Devices Market.
Competitive Landscape
Global Ophthalmological Devices Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, HAAG-Streit Group, Hoya Corporation, Johnson and Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Ophthalmological Systems AG, Volk Optical, Inc., and Leica Microsystems. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Ophthalmological Devices Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Ophthalmological Devices Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Ophthalmological Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable